Continuing Medical Education for Pharmacists | Earn Free CME Credits

Education

Search

Saved Activities

0 Activities

0 Activities

Filter Content

Page 1 of 2

Results 1 - 75 of 77

Beyond Routine Recovery: Treating Atypical Postpartum Complications

Beyond Preeclampsia: Recognizing and Responding to Rare Complications

Thrombotic Threats in Early Pregnancy: Unraveling Rare Blood Disorders

9362_hemophilia_263x149

Monograph: A New Era for Hemophilia Treatment: Common Goals, Unique Perspectives

9362_hemophilia_263x149

Symposium: A New Era for Hemophilia Treatment: Common Goals, Unique Perspectives

Am I Treating My Patients With Psoriatic Disease Effectively?

Unraveling Cancer Pain Dynamics Adaptive Learning Module: A REMS-Compliant CE Activity

9364-amyloidosis-263x149

Cleveland Clinic Tall Rounds: Post‐diagnostic Monitoring of Cardiac Amyloidosis

9362_hemophilia_263x149

Rapid Recap: A New Era for Hemophilia Treatment: Common Goals, Unique Perspectives

9364-amyloidosis-263x149

Cleveland Clinic Tall Rounds: Treating Confirmed ATTR

9341-weight-mgmt

Weight Management in Community Health: Bridging Systems and Care Coordination

9350_isth_micro3

Microlearning: Novel Approaches Under Investigation in Hemophilia

9350_isth_micro2

Microlearning: Neutralizing Antibodies in Hemophilia

9350_isth_micro1

Microlearning: Durability of Gene Therapy in Hemophilia

9299 mda enduring

Evolutions in the Management of DMD: Treatment Implications for the Present and Future

9278-isth-explore

Hemophilia Gene Therapy: Shared Decision Making - Clinical Companion Guide

9278-isth-explore

Risks and Benefits of Hemophilia Gene Therapy: An EXPLORE Learning Experience

A Changing Conversation: Delaying T1D Onset

9364-amyloidosis-263x149

Contemporary Strategies: Diagnosing ATTR Amyloidosis

animation-263x149

Encouraging Shared Decision-Making with MS Patients

Cognitive Impairment Associated With Schizophrenia

9235-0005_thumb

Recent Developments in Immune Therapies for Multiple Sclerosis

9235-mod4-263x149

The Connection Between Viruses and Other Factors Contributing to the Development of MS

Comorbidities and Selection of DMTs

Management of Breakthrough Disease Activity in MS

COVID-19 Associated ARDS

COVID-19 and Comorbid ILD

Minimizing Neurodegenerative Damage in Patients with MS

Recognizing Progressive Disease: A Challenge in the MS Clinic

DMT Treatment Review

IPF Animated Video Series: Micro-learning focusing on the soft skills

Palliative Care for mRCC

Salvage Therapies for Metastatic Renal Cell Carcinoma

Is There Still a Role For Cytoreductive Nephrectomy

Management of Rare RCC Histologies

Contemporary Topics in RCC: Tumor Board

End of Life in IPF

Comprehensive Care of the ILD Patient–Focus on Symptoms

Developing an Action Plan to Manage IPF

Diagnosis of Interstitial Lung Disease

Applying Principles of Pain Management

Patient Case: Osteoarthritis (OA) of the Knee

Patient Case: Lower Back Pain

Personalized Medicine for Improving Asthma Care: An Animated Video Series

Discussions with Patients to Optimize Asthma Control

9916-0004_treatment

Who Should be Targeted For Treatment With Biologic Therapy?

9916-0003_endotypes

Endotypes and Phenotypes in Asthma

Mechanisms of Action of Biologic Therapies for Severe Asthma

Approved Medications for the Treatment of Severe Asthma

9907-0006_shared

Engage Your Patients in Shared Decision-Making

9907-0005_cardio

Is It IPF or Cardiovascular Disease?

Interstitial Pneumonia with Autoimmune Features

9907-0003_pf-ild

How to Identify Progressive Fibrosing ILD

When Is It a Connective Tissue Disease?

9907-0001_guidelines

How to Use IPF Guidelines to Make a Diagnosis

Biosimilars: Applying the Science to Hematology/Oncology Practice

Considering Biosimilars in Patients Failing their Initial Biologic

When to Switch? Biologically Experienced Patients with Spondyloarthritis

Innovator or Biosimilar for a Patient with Rheumatoid Arthritis

IL-gastro-case3

Ulcerative Colitis: What Can You Expect When a Patient is Switched to a Biosimilar?

IL-gastro-case2

Biosimilars in Patients with Crohn’s Disease Failing an Initial Biologic

IL-gastro-case1

Innovator or Biosimilar for a Patient with Ulcerative Colitis?

Switching Between Biologics: Is a Biosimilar an Option?

When to Switch? Biologically Experienced Psoriasis Patients

Innovator or Biosimilar for a Patient with Psoriasis

Interchangeability and Pharmacy-Level Substitution

FDA Criteria: Biosimilar Approval, Manufacturing, & Naming

What is the Difference Between a Biosimilar and a Generic?

What is a Biologic?

Sorting it Out: Biologics, Biosimilars, Small Molecule Drugs, and Generics

Are You Ready to Use Biosimilars in Your Practice?

Health Care Providers’ Perspectives on Biosimilars: Based in Fact or Not?

Pharmacovigilance and Biosimilars: Any Special Considerations?

Interchangeability and Biosimilars: What will this Mean for Clinical Practice?

Can a Biosimilar be Used for the Same Indications Approved for the Reference Biologic?

Biosimilars: As Safe and Effective as the Reference Product?

Page 1 of 2